InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Alban Carlos. Director active across 3 companies, notably Solventum Corp. Aggregated, 8 filings have been published. Activity tracked since 14 July 2022. The latest transaction was disclosed on 30 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
ALBAN CARLOS is an insider, with 8 filings in total. Across the 8 sampled recent filings, both buy and sell amounts are 0 EUR, and the date range runs from 2022-07-15 to 2026-05-01. He is a Director at SpringWorks Therapeutics, Inc. and Solventum Corp, and the most frequent transaction nature shown is Attribution.